VivoSight Significantly Improves Early-Stage Diagnosis of Basal Cell Carcinoma and Reduces Need for Skin Biopsies 20th October 2015/in Pressemitteilungen, VivoSight /by martinRead more →
VivoSight at EADV Congress 2015 8th October 2015/in Pressemitteilungen, VivoSight /by martinRead more →
Transformative clinical results with VivoSight in the diagnosis of Basal Cell Carcinoma 12th June 2015/in Pressemitteilungen, VivoSight /by rupertRead more →
Michelson Diagnostics launches next generation OCT System – VivoSight Dx 30th April 2015/in Pressemitteilungen, VivoSight /by rupertRead more →
Landmark VivoSight OCT clinical study published in British Journal of Dermatology 29th April 2015/in Pressemitteilungen, VivoSight /by rupertRead more →
Peter Senger appointed as Germany Country Manager 13th April 2015/in Firma, Pressemitteilungen /by rupertRead more →
Michelson Diagnostics closes £2.5 million First Tranche of £4.0 million 9th February 2015/in Firma, Pressemitteilungen /by rupertRead more →
Andy Hill Appointed Chief Executive Officer 2nd February 2015/in Firma, Pressemitteilungen /by rupertRead more →
OCT Workshops – Dates Announced! 1st December 2014/in Pressemitteilungen, VivoSight /by rupertRead more →
